FDA approves new Alzheimer's drug
The FDA approved an Alzheimer's drug, which slows down the disease, according to phase 3 trial results. Leqembi is the first drug that's been shown to help slow memory decline in patients. But the drug does come with some potential safety risks. Katie McDonough, the community executive director of the Alzheimer's Association Southeastern Virginia Chapter joins FOX 5 to discuss the new drug.
Top Videos
FDA approves new Alzheimer's drug
DC weather: Scattered showers and thunderstorms Tuesday
Shooting investigation near DC hospital
Montgomery Co. Council to vote on updated ghost gun restrictions
Power line legal battle heads to Virginia Supreme Court
Man faces nearly 200 charges for car break-ins at Fairfax County gyms
50% tariffs slapped on hundreds of Canadian imports: Here's a list
Indictment in 3-month-old's murder; trial set for man charged with damaging Reflecting Pool
Montgomery County continues reducing speed limits on neighborhood and downtown roads.
Prince George’s County sees rise in marketplace meetup robberies
Near drowning at UDC pool; 2 shot near Washington Hospital Center
Ghost tours launch in Alexandria
Montgomery County passes new gun control legislation
Metro details Red Line upgrades plus planned shutdowns
D.C. Chair opposes House bill limiting the District's tax power
Search continues for driver in deadly Silver Spring hit-and-run
2 suspects wanted after shooting near D.C. school
Tropical Storm Bertha forms in Gulf | FOX 5 AT 6AM
Man charged after woman found dead at Sonesta Suites | FOX 5 AT 4AM
Missing autistic child rescued from water in Maryland
Loudoun County and Dominion push to pause power line project; Man charged after suspicious death
Prince George’s County police warn of increase in online meetup sale robberies
Maryland Gov. Moore tours Key Bridge site with federal lawmakers
D.C.-area farms see boost amid Cyclospora outbreak
Moving truck driver cited after 10-vehicle crash
